![Janet E. Buhlmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Dr. Janet E.
Buhlmann is a Director-Molecular Immunology at EpiVax, Inc.
She received her undergraduate degree from Mount Holyoke College and a doctorate degree from Dartmouth College.
Eerdere bekende functies van Janet E. Buhlmann
Bedrijven | Functie | Einde |
---|---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Corporate Officer/Principal | - |
Opleiding van Janet E. Buhlmann
Mount Holyoke College | Undergraduate Degree |
Dartmouth College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |